Loading...
Clinical utilization of long-acting granulocyte colony-stimulating factor (pegfilgrastim) prophylaxis in breast cancer patients with adjuvant docetaxel-cyclophosphamide chemotherapy
PURPOSE: Treatment with 4 cycles of docetaxel and cyclophosphamide (TC) in the adjuvant setting is associated with better outcomes than treatment with doxorubicin and cyclophosphamide (AC). However, Western guidelines have indicated that TC confers a high risk (>20%) of febrile neutropenia (FN),...
Na minha lista:
| Udgivet i: | Ann Surg Treat Res |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
The Korean Surgical Society
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7870427/ https://ncbi.nlm.nih.gov/pubmed/33585350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/astr.2021.100.2.59 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|